No Data
No Data
Artiva Biotherapeutics Director Yong-Jun Huh Buys $25m in IPO
IPO Roundup: Lineage, OneStream Software, and More
Is Artiva Biotherapeutics (NASDAQ:ARTV) In A Good Position To Deliver On Growth Plans?
Artiva Biotherapeutics Surges on Trading Debut
Express News | Trading Halt: Halt Status Updated at 10:10:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation
Biotechnology company Artiva Biotherapeutics (ARTV.US) IPO priced at $12 per share and will debut on Nasdaq tonight.
Artiva Biotherapeutics has announced the IPO terms, issuing 13.9 million shares of stock at a price of $12 per share, raising $167 million.
No Data
71875619 : when were you in? when it was falling or rising?